Price transparency and surprise billing protections
Hospitals and insurers face increasing pressure to make prices intelligible for patients.
Rules requiring disclosure of negotiated rates and out-of-pocket cost estimates aim to reduce surprise bills and give consumers more power when choosing providers. At the same time, federal protections against surprise emergency and out-of-network bills strengthen patient financial security. These measures are changing negotiation dynamics between payers and providers and encouraging more proactive cost conversations during scheduling and care planning.
Telehealth and hybrid care models
Telehealth has moved from an emergency workaround to a core component of care delivery for primary care, behavioral health, and chronic disease management. Policymakers are working to cement telehealth access by clarifying reimbursement rules, licensure flexibility, and privacy standards. Expect continued emphasis on hybrid models that combine virtual and in-person visits to improve access while maintaining continuity of care. Ensuring broadband access and addressing state licensure fragmentation remain priorities to make telehealth equitable and sustainable.
Drug pricing and affordability
High prescription costs remain a top concern for patients and policymakers.
Recent policy efforts target greater negotiation power for public payers, enhanced transparency about manufacturer pricing strategies, and incentives for lower-cost alternatives like biosimilars and generics. Initiatives that reduce out-of-pocket costs at the pharmacy counter and align incentives for value-based purchasing are gaining traction as ways to improve affordability without undermining innovation.
Medicare Advantage and payment reform
Private plans within Medicare are growing, prompting scrutiny of plan design, network adequacy, and quality measurement. Payment models that shift risk to providers — coupled with quality-based bonuses — are nudging the system toward value-based care. Alternative payment models that reward outcomes rather than volume are expanding across public and private payers, with a focus on care coordination, social determinants of health, and reducing unnecessary hospitalizations.
Medicaid, access, and social determinants
State-level decisions about Medicaid expansion and program design continue to affect access to coverage and services for low-income populations. Policymakers are increasingly integrating social services into Medicaid through waivers and managed care arrangements to address food insecurity, housing instability, and behavioral health needs. These approaches recognize that health outcomes depend on nonmedical supports as much as clinical interventions.
Workforce and care delivery capacity
Provider shortages — particularly in primary care, behavioral health, and rural areas — are shaping policy priorities around training, loan forgiveness, scope-of-practice reforms, and telehealth-enabled teams. Efforts to diversify the workforce and expand community-based roles like community health workers are intended to boost capacity while improving cultural competence and access.
Data, interoperability, and patient-centered care
Interoperability rules and efforts to reduce information blocking aim to make health data more portable and actionable for patients and providers. Better data sharing supports care coordination, lowers duplication of services, and enables value-based payment models. Privacy safeguards and clear standards for patient access remain critical to maintain trust while unlocking the benefits of connected data systems.
How this affects patients and providers
Patients should expect clearer cost estimates, more virtual care options, and stronger protections against surprise bills.
Providers and health systems will find themselves adapting to new payment models, investing in technology and care coordination, and focusing on measurable outcomes. Stakeholders who stay informed and engage with policymakers can shape solutions that balance affordability, access, and quality.
What to watch
Keep an eye on evolving rules around price transparency, telehealth reimbursement, drug affordability initiatives, and efforts to align payment with patient-centered outcomes. Those developments will determine how quickly policy intentions translate into tangible improvements at the point of care.